1. Acerbi D, Bonati C, Boscarino G, Bufalino L, Cesari F, et al. Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin. International Journal of Clinical Pharmacology Research 8: 175–180, 1988
2. Arakawa T, Nakamura H, Satoh H, Chono S, Yamada H, et al. Prostaglandins in the rat gastric mucosa (10th report). Effect of beta cyclodextrin clathrate of 2-benzoyl-carbonylphenyl-trans-4-guanidine-methyl cyclohexane carboxylate hydrocholine (TA903) on mucosal prostaglandins. Nippon Shokakibyo Gak-kai Zasshi 81: 1554–1558, 1981
3. Brewster ME, Estes KS, Loftsson T, Perchalski R, Derendorf H, et al. Improved delivery through biological membranes. XXXL: solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. Journal of Pharmaceutical Sciences 77: 981–985, 1988
4. Cockel R. NSAIDs — should every prescription carry a government health warning? Gut 28: 515–518, 1987
5. Corrigan OI, Stanley CT. Mechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systems. Journal of Pharmacy and Pharmacology 34: 621–626, 1982